Tmunity Therapeutics Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Tmunity Therapeutics's estimated revenue is currently $8.7M per year.
- Tmunity Therapeutics received $35.0M in venture funding in April 2018.
- Tmunity Therapeutics's estimated revenue per employee is $144667
- Tmunity Therapeutics's total funding is $150M.
- Tmunity Therapeutics has 60 Employees.
- Tmunity Therapeutics grew their employee count by 54% last year.
- Tmunity Therapeutics currently has 1 job openings.
|Usman Azam||President & CEO|
|Zoe Zheng||Senior Director, Process Development|
|Kimberly Smith||VP of Finance and Corporate Controller|
|Lori Gavrin||Executive Director of Business Development|
|Jason Krentz||Chief Technology Officer - Head of Technical Operations|
|David Geoghegan||Vice President, Head of Quality|
|Sandy Matalonis||Senior Director, Portfolio and Project Management|
|John Delyani||Vice President, Corporate and Business Development|
|Dan Winand||Director, Technical Operations and Manufacturing Program Management|
|Melanie Tellers||Senior Director, CMC Regulatory Affairs|
What Is Tmunity Therapeutics?
Our vision is to become the leading innovative global life-sciences company that unlocks the potential of T-cell biology and combines it with the power of T-cell engineering excellence to provide cures for patients. Through our model of seamless and rapid integration of research, translational medicine, manufacturing science, clinical development and customer-centric approaches, we will design and deliver enhanced state-of-the-art solutions for patients in a host of disease areas using Chimeric Antigen Receptors (CARs), Gene edited T-Cells, T regulatory cells (Treg), and engineered T Cell Receptors (TCRs)keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Tmunity Therapeutics News
PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and ...
“As therapeutic developers utilizing gene-editing technologies, we must ... Therapeutics, Precision Biosciences, and Tmunity Therapeutics.
SAN FRANCISCO—Nearly a year after Tmunity Therapeutics raised $100 million to develop better and safer T cell treatments, the company is ...
Tmunity Therapeutics Funding
Tmunity Therapeutics Executive Hires
|2017-05-10||Michael Christiano||EVP and Chief Business Officer||Article|
|2018-04-04||Jason Krentz||CTO & Head of Technical Operations||Article|
|2018-07-11||Christina Coughlin||Chief Medical Officer/evp||Article|
|2018-09-19||Moji James||General Counsel & EVP||Article|